Further experience with gastric stimulation to treat drug XXXX .

@entity1 @entity3916 @entity6 @entity358 @entity7623 @entity356
BACKGROUND: Gastric electrical stimulation (GES) has been introduced for @entity1 with @entity7623 refractory to pharmacological therapy. METHODS: From April 1998 until November 2001, 55 @entity1 underwent GES implantation at Kansas University Medical Center. All @entity1 had prolonged @entity356 of a solid meal by scintigraphy at baseline. The etiologies were @entity6 in 39, related to previous surgery in 9, and idiopathic in 7. Symptoms were graded using a 5-point scale and quality of life was assessed with the SF-36 questionnaire. Body mass index and nutritional parameters were monitored. Hemoglobin @entity3916 was measured in the @entity6 @entity1 . RESULTS: Total symptom scores and the physical and mental composite scores of quality of life improved significantly. On average, gastric emptying did not change. Body mass index and body weight increased significantly. And days spent in hospital admissions were significantly decreased. At 1 year, @entity6 @entity1 experienced reduced hemoglobin @entity3916 . Four devices were removed. One @entity1 died of a @entity358 postoperatively. CONCLUSIONS: In a large series of @entity1 with @entity7623 , GES significantly improved symptoms and quality of life.
